Solid Tumor Therapeutics Market

Solid Tumor Therapeutics Market Size by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer Types), by Drug Type (Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Doxorubicin, Bevacizumab, Erlotinib, Sunitib, Everolimusa, Other drug types), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-14006
  • Published Date: Jan, 2024
  • Pages: 238
  • Category: Information Technology & Semiconductors
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global Solid Tumor Therapeutics market was valued at USD 222.71 billion in 2023 and growing at a CAGR of 14.80% from 2024 to 2033. The market is expected to reach USD 885.44 billion by 2033. Increasing investments of Pharmaceutical companies in R&D and the global rise in the number of cancer patients are the major driving factors propelling the growth of the Solid Tumor Therapeutics Market Whereas, rising government initiatives towards cancer cases and rising numbers of active market players may also provide lucrative opportunities for the growth of the Solid Tumor Therapeutics Market.

Market Introduction:

Solid Tumor Therapeutics is the type of medical treatment used to treat solid tumors which are found in different types of body parts. These types of cancers range from, Lung, prostate, Breast, Cervical cancer, and others.

The market is bifurcated among various drug types, ranging from Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Doxorubicin, and others. The rising number of cancer patients has propelled the growth of the Solid Tumor Therapeutics Market. For instance: According to the European Breast Cancer Coalition 2022 report. Every 1 in 11 women develop breast cancer before the age of 74.

Solid Tumor Therapeutics Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • In November 2023, AbbVie acquired ImmunoGen. The main objective behind this acquisition was to build and expand a strong portfolio base for the Solid Tumor Therapeutics Market. This acquisition will further boost AbbVie’s entry into the commercial market for Ovarian cancer.
  • In Sept 2023, Allogene Therapeutics launched ALLO-182, thereby focusing on defining an early-stage solid tumor product candidate. This launch will be an important functional area that will help the organization to expand its potential for CAR-T products.
  • CARsgen Therapeutics Holdings Limited entered into collaboration with Moderna Inc., the main objective of this collaboration was to investigate CARsgen’s investigational Claudin. The main aim of this collaboration was to work on the treatment of gastric, pancreatic, and other specified digestive systems.

Market Dynamics:

Drivers

Increasing investments of pharmaceutical companies in Research & Development - A huge chunk of pharmaceutical companies continue to make significant contributions to the development of experimental drugs and technologies. The pharmaceutical sector, for instance, is significantly invested in research and development. Pharmaceutical firms invest in future research to bring high-quality, pharmaceuticals to the marketplace.  Major pharma firms are boosting their R&D efficiency by investing heavily in R&D, to ensure long returns on investments, as well as by collaborating with the R&D centers worldwide. for instance: According to Statista, Roche is expected to be the world’s largest company which is investing heavily in R&D, that is, USD 14 Billion followed by Johnson & Johnson (USD 12.2 Billion), Merck & Co (USD 11.4 Billion), Pfizer (USD 10.5 Billion) and Novartis (USD 10 Billion), by the year 2026.

Restraints:

Increasing operation cost and the price to cure cancer- Tremendous involvement of operation cost to cure the tumor is one major restraint that may hamper the growth of the Solid Tumor Therapeutics Market. With higher prices involved with curing tumor cells, patients get limited access to high-quality treatment for cancer.

Opportunities:

Rising government initiatives towards cancer cases – Governments across various countries have taken active measures to spread awareness about treating cancer. For instance, the Indian government has started raising about treating cancer cases not only over offline media (boards, hoardings, In-store advertisements, In-mall activations) but also over online channels (Social media channels, TV, radio, and others).

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global Solid Tumor Therapeutics market, accounting for 44% of the total market share globally. Primarily owing to the increasing number of cancer cases and established numbers of healthcare and private clinics/hospitals in the region. Whereas, Asia-Pacific is the fastest-growing region, after North America, owing to increasing Research & Development centers in the region.

Asia Pacific Region Solid Tumor Therapeutics Market Share in 2023 - 23%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Cancer Type Segment Analysis

Prostate cancer has dominated the Solid Tumor Therapeutics Market, thereby capturing the market share of 47% in the Global Solid Tumor Therapeutics Market, in the year 2023. Owing to the rising number of solid tumors in males and Prostate cancer, Breast Cancer is the fastest-growing segment in the market, thereby registering the fastest growth of 17.5% in the market. Owing to the rapidly increasing number of breast cancer patients and an increasing number of market players in the market.

Drug Type Industry Segment Analysis

Bevacizumab has dominated the market owing to the increasing number of cancer patients in the market, and the increasing need to lower the growth of cancer cells in the market. Whereas, Carboplatin has witnessed the fastest growth rate in the market. Owing to the increase in side effects of cancer in the market.

Some of the Key Market Players:
  • Abbott Laboratories Inc
  • Amgen Inc
  • AstraZeneca PLC
  • Baxter International Inc
  • Biogen Inc
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 222.71 Billion
Market size value in 2033 USD 885.44 Billion
CAGR (2024 to 2033) 14.80%
Historical data 2020-2022
Base Year 2023
Forecast 2024-2033
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Cancer Type, Drug Type

Frequesntly Asked Questions

As per The Brainy Insights, the size of the solid tumor therapeutics market was valued at USD 222.71 billion in 2023 to USD 885.44 billion by 2033.

The global Solid Tumor Therapeutics market is growing at a CAGR of 14.80% during the forecast period 2024-2033.

The Asia Pacific region emerged as the largest market for the solid tumor therapeutics.

The increasing investments of pharmaceutical companies in research & development will influence the market's growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Cancer Type
          4.3.2. Market Attractiveness Analysis by Drug Type
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing investments of Pharmaceutical companies in R&D
          5.2.2. Global rise in the number of cancer patients
    5.3. Restraints
          5.3.1. Increasing operational costs
    5.4. Opportunities
          5.4.1. Rising government initiatives towards cancer cases
          5.4.2. Rising numbers of active market players
    5.5. Challenges
          5.5.1. Side effects associated with solid tumor therapeutics in the market

6. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Cancer Type
    6.1. Segment Overview
    6.2. Breast Cancer
    6.3. Lung Cancer
    6.4. Colorectal Cancer
    6.5. Prostate Cancer
    6.6. Cervical Cancer
    6.7. Other Cancer Types

7. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Drug Type
    7.1. Segment Overview
    7.2. Carboplatin
    7.3. Cisplatin
    7.4. Gemcitabine
    7.5. Paclitaxel
    7.6. Doxorubicin
    7.7. Bevacizumab
    7.8. Erlotinib
    7.9. Sunitinib
    7.10. Everolimusa
    7.11. Other Drug Types

8. Global Solid Tumor Therapeutics Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Solid Tumor Therapeutics Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Solid Tumor Therapeutics Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
          10.1.1. Abbott Laboratories Inc
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Amgen Inc
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Astra Zeneca PLC
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Baxter International Inc
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Biogen Inc
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Boehringer Ingelheim GmbH
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Bristol-Myers Squibb Company
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Eli Lilly and Company
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. F. Hoffmann-La Roche AG
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. GlaxoSmithKline PLC
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
 

List of Table

1. Global Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

2. Global Breast Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion) 

3. Global Lung Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

4. Global Colorectal Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion) 

5. Global Prostate Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

6. Global Cervical Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion) 

7. Global Other Cancer Types Cancer, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

8. Global Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

9. Global Carboplatin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

10. Global Cisplatin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

11. Global Gemcitabine, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

12. Global Paclitaxel, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

13. Global Doxorubicin, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

14. Global Bevacizumab, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

15. Global Erlotinib, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

16. Global Sunitinib, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

17. Global Everolimusa, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

18. Global Other Drug Types, Solid Tumor Therapeutics Market, By Region, 2020-2033(USD Billion)

19. North America Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

20. North America Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

21. U.S. Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

22. U.S. Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

23. Canada Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

24. Canada Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

25. Mexico Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

26. Mexico Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

27. Europe Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

28. Europe Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

29. Germany Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

30. Germany Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

31. France Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

32. France Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

33. U.K. Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

34. U.K. Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

35. Italy Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

36. Italy Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

37. Spain Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

38. Spain Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

39. Asia Pacific Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

40. Asia Pacific Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

41. Japan Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

42. Japan Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

43. China Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

44. China Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

45. India Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

46. India Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

47. South America Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

48. South America Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

49. Brazil Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

50. Brazil Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

51. Middle East and Africa Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

52. Middle East and Africa Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

53. UAE Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

54. UAE Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

55. South Africa Solid Tumor Therapeutics Market, By Cancer Type, 2020-2033(USD Billion)

56. South Africa Solid Tumor Therapeutics Market, By Drug Type, 2020-2033(USD Billion)

List of Figures 

1. Global Solid Tumor Therapeutics Market Segmentation

2. Global Solid Tumor Therapeutics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Cancer Type

9. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Drug Type

10. Global Solid Tumor Therapeutics Market Attractiveness Analysis by Region

11. Global Solid Tumor Therapeutics Market: Dynamics

12. Global Solid Tumor Therapeutics Market Share by Cancer Type (2024 & 2033)

13. Global Solid Tumor Therapeutics Market Share by Drug Type (2024 & 2033)

14. Global Solid Tumor Therapeutics Market Share by Regions (2024 & 2033)

15. Global Solid Tumor Therapeutics Market Share by Company (2023)

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global solid tumor therapeutics market based on below-mentioned segments:

Global Solid Tumor Therapeutics Market by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Other Cancer Types

Global Solid Tumor Therapeutics Market by Drug Type:

  • Carboplatin
  • Cisplatin
  • Gemcitabine
  • Paclitaxel
  • Doxorubicin
  • Bevacizumab
  • Erlotinib
  • Sunitinib
  • Everolimusa
  • Other Drug Types

Global Solid Tumor Therapeutics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date